SS
INO icon

Simplicity Solutions’s Inovio Pharmaceuticals INO Stock Holding History

Simplicity Solutions’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,201
Closed -$21.7K – 1130
2023
Q1 		$21.7K Buy
+2,201
New +$37.5K ﹤0.01% 1133
2020
Q3 		– Sell
-750
Closed -$243K – 901
2020
Q2 		$243K Buy
+750
New +$120K ﹤0.01% 782

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Simplicity Solutions's INO Position: Q2 2023 in Review

Simplicity Solutions sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 2,201 shares — an estimated $21.7K sold.

Simplicity Solutions first reported a position in INO in Q2 2020 and held it in 2 quarters. The position peaked at $243K in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Simplicity Solutions reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Simplicity Solutions sold 2,201 Inovio Pharmaceuticals shares in Q2 2023, an estimated $21.7K.
  • Simplicity Solutions first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Simplicity Solutions's Inovio Pharmaceuticals position peaked at $243K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Simplicity Solutions's 13F filing for Q2 2023, filed 26 Jul 2023.